AI plus lab analyses link NAD-mitophagy axis to brain aging and neurodegeneration
In an abstract, analyses of public human brain data plus worm, cell and stem-cell models found the NAD-mitophagy axis more severely dysregulated in neurodegeneration than in brain aging and named five Alzheimer-protective genes. [1]
Automatic summary · not editorially reviewed
The key findings
Transcriptomic data from 12 human brain regions across 77 integrated public datasets were analyzed, focusing on Alzheimer's disease. [1]
The NAD-mitophagy axis was more severely dysregulated in neurodegeneration than in brain aging. [1]
Five Alzheimer-protective genes were identified and linked to synaptic resilience and/or reduced Tau pathology. [1]
The source at a glance
- Study type / format
- Abstract of a computational and experimental study
- Population / context
- Human brain transcriptomic datasets and worm, Tau cell and stem-cell-derived neuron models
- Summary based on
- Study abstract
- Original publication
- August 1, 2026
Public brain datasets and model validation
The authors analyzed transcriptomic data from 12 human brain regions across 77 integrated public datasets covering major neurodegenerative diseases and controls, focusing on Alzheimer's disease. Key targets were then checked in Caenorhabditis elegans, a human Tau cell model and induced pluripotent stem cell-derived cortical neurons. The abstract does not report sample sizes for these model experiments.
Supporting source [1]
Stronger dysregulation in neurodegeneration than brain aging
According to the abstract, the NAD-mitophagy axis was more severely dysregulated in neurodegeneration than in brain aging. By combining computational and experimental approaches, the authors identified five Alzheimer-protective genes: ULK1, OPA1, LAMP2, MFN1 and ATP6V0E1. These were linked to synaptic resilience and/or reduced Tau pathology. The abstract describes associations and model findings, not proven causes or human lifespan benefits.
Supporting source [1]
Proposed targets, not validated treatments
The discussion presents the combination of artificial intelligence-driven and experimental approaches as a way to identify novel targets for neurodegeneration, with disruption of the NAD-mitophagy axis described as a central player in brain aging and Alzheimer's disease. The abstract reports no clinical trial, no intervention and no outcome in people; the five genes are proposed targets rather than validated therapies.
Supporting source [1]
How to interpret this
This explainer is based only on the abstract; the full text was not reviewed. The abstract reports no sample sizes for the model experiments, no clinical trial and no human outcome data. Findings are associations and preclinical model results, not proven causes or human lifespan benefits.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Lautrup S, Cao SQ, Long X, Liu BHM, Escobar-Doncel B, Ferrante A, Frank J, Schmauck-Medina T, Leung GHD, Liang KX, Lu N, Veverova K, Vyhnalek M, Pun FW, Zhavoronkov A, Fang EF. · europepmc.org · August 1, 2026